Athens Medical C.S.A. (ATH:IATR)

Market Cap	170.00M +16.3%
Revenue (ttm)	270.92M +1.6%
Net Income	-4.73M
EPS	-0.05
Shares Out	86.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (1.02%)
Ex-Dividend Date	n/a

Volume	6,471
Average Volume	11,482
Open	1.975
Previous Close	1.975
Day's Range	1.910 - 1.975
52-Week Range	1.560 - 2.350
Beta	0.83
RSI	49.98
Earnings Date	Apr 30, 2026

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,515
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

In 2024, Athens Medical C.S.A.'s revenue was 269.85 million, an increase of 4.44% compared to the previous year's 258.36 million. Earnings were 1.78 million, a decrease of -77.99%.